Joel Muller

Joel Muller, CPA, is an experienced finance and accounting professional currently serving as Director of Finance & Accounting at Innoviva Specialty Therapeutics, Inc. since September 2023. Prior to this role, Joel held positions such as Associate Director of Accounting at both Bristol Myers Squibb and Turning Point Therapeutics, where notable contributions followed the $4.1 billion acquisition of Turning Point by Bristol Myers Squibb. Joel's background includes significant roles at La Jolla Pharmaceutical Company, Mission Brewery, 3M, and Ivera Medical, demonstrating expertise across various industries, including pharmaceuticals, craft brewing, and medical technology. With a Master of Science in Accountancy from San Diego State University and a Bachelor of Science in Management Science from UC San Diego, Joel's educational foundation supports a robust professional trajectory.